Skip to content
    Point72 logo

    Point72

    Stamford, Connecticut, United StatesFounded 2014

    Point72 is a leading global alternative investment firm led by Steven A. Cohen that deploys fundamental equities, systematic, macro, private credit, and venture capital strategies. Founded in 2014 as the successor to S.A.C. Capital Advisors, it is headquartered in Stamford, Connecticut.

    43% of their portfolio is in Fintech. Their most common stage is series-c (43% of deals). Average disclosed round size is $68.5M (across 4 rounds with reported amounts).

    Find people at Point72 on Goldilocks AI

    Portfolio

    6

    Fund Size

    —

    Top Stage

    Series C

    Last 12 Mo

    0

    Team

    Jaimi Goodfriend

    Jaimi Goodfriend

    Head of Investment Professional Development, Point72 Academy Director

    GO

    Gavin O’Connor

    Executive Vice President

    Andrew B. Cohen

    Andrew B. Cohen

    Chief Investment Officer, Cohen Private Ventures

    Elena Bukowski

    Elena Bukowski

    Global Head of Capital Development and Investor Relations

    Harry Schwefel

    Harry Schwefel

    President and Co-Chief Investment Officer

    Steven A. Cohen

    Steven A. Cohen

    Chairman, Chief Executive Officer, and Co-Chief Investment Officer

    Becca Mitchell

    Becca Mitchell

    Co-Head of Corporate Communications

    Brooke Trahan

    Brooke Trahan

    Chief Intelligence Officer

    Dan Lota

    Dan Lota

    Global Head of Trading

    Geoffrey Lauprete

    Geoffrey Lauprete

    Head of Cubist Systematic Strategies

    Gina DiMento

    Gina DiMento

    Chief Compliance Officer

    Ilya Gaysinskiy

    Ilya Gaysinskiy

    Chief Technology Officer

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    7 investments
    CompanyRoundAmountDate
    Spore Biotechnologies logoSpore BiotechnologiesSeries A—Feb 2025
    Pagos logoPagosSeries A$34MFeb 2023
    Vestwell logoVestwellSeries C$70MJul 2021
    Arch Oncology, Inc. logoArch Oncology, Inc.Series C$105MApr 2021
    Vestwell logoVestwellSeries B—Jan 2019
    Porch logoPorchSeed$65MJan 2015
    EliseAI logoEliseAISeries C——

    Top Co-Investors

    Last updated: 27 September 2026